Amgen Inc. - Company & Market Research Reports

Home /
Companies /
Amgen Inc.

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 332
Immune Disorders Drugs 206
Biopharmaceuticals 175
Musculoskeletal Disorders Drugs 125
Genomics 115
Cardiovascular Drugs 104
Biotechnology 85
Pharmaceuticals 82
Drug Discovery 77
Endocrine and Metabolic Disorders Drugs 76
Biosimilars and Biosuperiors 72
Allergy and Immunology 65
Leukemia Drugs 63
Infusions and Injectables 63
Hematological Drugs 60
Dermatological Drugs 53
Oncology 52
Clinical Trials 51
Central Nervous System Drugs 49
Liver and Kidney Disorders Drugs 45
Women's Health 44
Needles and Syringes 40
Drug Delivery 38
Psoriasis Drugs 37
Diagnostics 36
Skin Cancer Drugs 35
Hematology 30
Infectious Diseases Drugs 28
Brain Cancer Drugs 28
Enzymes 27
Gastrointestinal Drugs 27
Lung Cancer Drugs 26
Colon Cancer Drugs 26
Proteomics 26
Analgesics 24
Immunosuppressive Drugs 24
Lymphoma Drugs 23
Pharmaceutical Manufacturing 19
Drugs by Therapeutic Area 18
Optical 17
Dermatology 17
Therapeutic Area 16
Urology and Nephrology 15
Respiratory Drugs 15
Healthcare Services 14
Kidney Cancer Drugs 14
Optical Disorders Drugs 13
Pancreatic Cancer Drugs 12
Nanomedicine 11
Generic Drugs 10
Breast Cancer Drugs 10
Prostate Cancer Drugs 10
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Sexual and Reproductive Health Drugs 10
E-Healthcare 9
Biomarkers 9
Cardiology 9
Liver Cancer Drugs 8
Cancer Vaccines 8
Other Healthcare Facilities 8
Gastroenterology 8
Pulmonary Medicine 7
In Vitro Diagnostics 7
Anti-Obesity Drugs 7
Neurology 6
Diabetes Drugs 6
Biomaterials 6
Vaccines 6
Mental Disorders Drugs 6
Company Reports 5
Animal Pharmaceuticals 5
Medical Devices 5
Molecular Diagnostics 5
Over the Counter (OTC) Drugs 5
Pediatrics 5
Asthma Drugs 5
Pharmaceutical Intermediates 4
Surgical Procedures 4
Thyroid Cancer Drugs 4
Alzheimer's Disease Drugs 4
Managed Care 3
Stem Cells 3
Endocrinology 3
Addiction Disorders Drugs 2
Bladder Cancer Drugs 2
Cardiovascular Devices 2
Infectious Disease Testing 2
Inhalers and Nebulisers 2
Mental Health 2
Uterine Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Antibiotics 2
Acne Drugs 2
Urological Disorders Drugs 2
Schizophrenia Drugs 2
Hepatology 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Orthopedic Devices 1
Cholesterol Testing 1
Cough and Cold Drugs 1
Healthcare 1
Radiography 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Hospital Management 1
Respiratory Devices 1
Clinical Therapies 1
Clinical Skills 1
Palliative Care 1
Anatomy 1
Maternal and Neonatal Care 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



283 reviews

2,079 Results (Page 52 of 104)
- Relevance
  Sort by

Interleukin 1 Receptor Associated Kinase 4 Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2022
86 Pages
Global

From

€3500EUR$4,123USD£3,104GBP

Melanoma Therapeutics Market Size, Share & Trends Analysis Report By Product (Chemotherapy, Immunotherapy), By Drug Type (Branded Drugs, Generic Drugs), By Region, And Segment Forecasts, 2023 - 2030

 Report
September 2023
100 Pages
Global

From

€5411EUR$5,950USD£4,636GBP

Breast Cancer Therapeutics Market 2024-2028

 Report
January 2024
168 Pages
Global

From

€2274EUR$2,500USD£1,948GBP

Protein Engineering Market Size, Share, Trends and Forecast by Product & Services, Protein Type, Technology, End User and Region, 2026-2034

 Report
April 2026
140 Pages
Global

From

€3637EUR$3,999USD£3,116GBP

Cervical Cancer - Market Insight, Epidemiology and Market Forecast - 2034

 Report
March 2024
225 Pages
Global

From

€7230EUR$7,950USD£6,194GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Digital Health in Immunology - Thematic Research

 Report
December 2021
57 Pages
Global

From

€1773EUR$1,950USD£1,519GBP

Physical Therapy Software Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4083EUR$4,490USD£3,498GBP

Cytokine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
185 Pages
Global

From

€4092EUR$4,500USD£3,506GBP

Migraine Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
269 Pages
Global

From

€1819EUR$2,000USD£1,558GBP

Growth Factors Market - Global Forecast 2026-2030

 Report
January 2026
198 Pages
Global

From

€3224EUR$3,545USD£2,762GBP

€3582EUR$3,939USD£3,069GBP

Immuno-Oncology - Thematic Research

 Report
May 2022
167 Pages
Global

From

€1773EUR$1,950USD£1,519GBP

Erythropoietin Stimulating Agents Market 2026-2030

 Report
January 2026
303 Pages
Global

From

€2274EUR$2,500USD£1,948GBP

Protein Engineering Market Report 2026

 Report
January 2026
250 Pages
Global

From

€4083EUR$4,490USD£3,498GBP

Difficult-to-Express Proteins Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4083EUR$4,490USD£3,498GBP

Rheumatology Therapeutics - Global Strategic Business Report

 Report
July 2026
196 Pages
Global

From

€5320EUR$5,850USD£4,558GBP

Connective Tissue Diseases - Global Strategic Business Report

 Report
July 2026
385 Pages
Global

From

€5320EUR$5,850USD£4,558GBP

Skeletal Dysplasia Market - Global Strategic Business Report

 Report
July 2026
378 Pages
Global

From

€5320EUR$5,850USD£4,558GBP

Cervical Spondylosis Treatment Market - Global Strategic Business Report

 Report
July 2026
374 Pages
Global

From

€5320EUR$5,850USD£4,558GBP

Andersen-Tawil Syndrome (ATS) Market - Global Strategic Business Report

 Report
July 2026
276 Pages
Global

From

€5320EUR$5,850USD£4,558GBP

Osteonecrosis Treatment - Global Strategic Business Report

 Report
July 2026
382 Pages
Global

From

€5320EUR$5,850USD£4,558GBP

2,079 Results (Page 52 of 104)
- 1
- 50
- 51
- 52
- 53
- 54

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.